Achieving target LDL-C level in secondary prevention; Cardiologists vs. primary care physicians: Results of the active lipid management in coronary artery disease (ALMICAD) study

被引：0
|
作者：
Sinno, Mohamad [1 ]
Al-Mallah, Mouaz [1 ]
Srivastava, Ajay [1 ]
Khanal, Sanjaya [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
CIRCULATION | 2006年 / 113卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E816 / E816
页数：1
相关论文
共 7 条
  • [1] Randomized controlled trial of specialized lipid clinic versus conventional care management of hyperlipidemia in patients with coronary artery disease: Results of the active lipid management in coronary artery disease (ALMICAD) study
    Khanal, S
    Obeidat, O
    Bloome, M
    Lu, M
    Douthat, L
    Hudson, MP
    Greenbaum, AB
    Kugelmass, A
    Weaver, WD
    CIRCULATION, 2004, 110 (17) : 802 - 802
  • [2] Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? Results from the DA VINCI study
    Siostrzonek, Peter
    Brath, Helmut
    Zweiker, Robert
    Drexel, Heinz
    Hoelzl, Robert
    Hemetsberger, Margit
    Ray, Kausik K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (7-8) : 294 - 301
  • [3] Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?Results from the DA VINCI study
    Peter Siostrzonek
    Helmut Brath
    Robert Zweiker
    Heinz Drexel
    Robert Hoelzl
    Margit Hemetsberger
    Kausik K. Ray
    Wiener klinische Wochenschrift, 2022, 134 : 294 - 301
  • [4] LIPID LOWERING THERAPY IN PRIMARY AND SECONDARY PREVENTION ACROSS EUROPE: ARE LDL-C GOALS ACHIEVED? RESULTS FROM THE DA VINCI STUDY
    Ray, K. K.
    Schoonen, W. M.
    Catapano, A. L.
    Giovas, P.
    Bray, S.
    Molemans, B.
    Poulter, N.
    ATHEROSCLEROSIS, 2020, 315 : E13 - E13
  • [5] Are coronary patients on lipid-lowering therapy in Europe achieving the recommended LDL-C target? Results from the Dyslipidemia International Study (DYSIS) II Europe
    Gitt, A. K.
    Ferrieres, J.
    De Ferrari, G.
    Elisaf, M.
    Hermans, M. P.
    Kiernan, T.
    Oganov, R.
    Lautsch, D.
    Ashton, V.
    Ambegaonkar, B.
    EUROPEAN HEART JOURNAL, 2015, 36 : 286 - 286
  • [6] Impact of Type 2 Diabetes on Optimal Target LDL-C Level for Secondary Prevention of Cardiovascular Disease in Patients With Acute Coronary Syndrome: A Subanalysis of HIJ-PROPER
    Sekiguchi, Haruki
    Kawada-Watanabe, Erisa
    Arashi, Hiroyuki
    Yamaguchi, Junichi
    Ogawa, Hiroshi
    Hagiwara, Nobuhisa
    CIRCULATION, 2017, 136
  • [7] COST-EFFECTIVENESS OF STATIN THERAPY FOR SECONDARY PREVENTION AMONG PATIENTS WITH CORONARY ARTERY DISEASE WITH BASELINE LDL-C LEVEL OF 70-100 MG/DL IN TAIWAN
    Lin, F.
    Shau, W.
    Wen, Y.
    Li, J. Z.
    Fung, S. S.
    Inocencio, T.
    Gao, X.
    Yeh, H.
    VALUE IN HEALTH, 2018, 21 : S30 - S30
1